CGS-12066A je lek koji deluje kao potentan i selektivanagonist za 5-HT1Breceptora sa nižim afinitetom za tri 5-HT2 receptorska tipa.[1][2] On se koristi za istraživanje uloge 5-HT1B receptora u različitim procesima uključujući percepciju bola, kao i cikluse spavanja i budnost.[3][4]
^Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Aug;370(2):114-23. . PMID15322733. doi:10.1007/s00210-004-0951-4.Недостаје или је празан параметар |title= (помоћ)
^Jeong HS, Jang MJ, Park JS. Effects of CGS-12066A on medial vestibular nuclear neurons. Brain Research. 15 March 2005;1038(1):118-21. PMID15748881
^Monti JM, Jantos H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Progress in Brain Research. 2008;172:625-46. PMID18772053
^Granados-Soto V, Argüelles CF, Rocha-González HI, Godínez-Chaparro B, Flores-Murrieta FJ, Villalón CM. The role of peripheral 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F serotonergic receptors in the reduction of nociception in rats. Neuroscience. 20 January 2010;165(2):561-8. PMID19837141
Y
